News

For the sixth consecutive year, Eli Lilly and Company has received a 100 percent rating on the Human Rights Campaign (HRC) Corporate Equality Index (CEI) for lesbian, gay, bisexual and transgender (LGBT) equality in the workplace. ...

Takeda Pharmaceutical Company Limited announced that at the request of the European Commission (EC), the European Medicines Agency (EMA)’s Committee for Medical Products for Human Use (CHMP) has clarified the label changes for pioglitazone-containing medicines recommended in July of...

Amylin Pharmaceuticals, Inc., and Eli Lilly and Company announced that the U.S. Food and Drug Administration (FDA) has approved a new use for BYETTA® (exenatide) injection. BYETTA is now approved as an add-on therapy to insulin glargine, with...

Vertex Pharmaceuticals Incorporated announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for KALYDECO™ (VX-770, ivacaftor), a medicine in development that targets the defective protein that causes cystic fibrosis (CF)....

Oxford BioMedica plc, the leading gene-based biopharmaceutical company, announces that the US Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for the Phase I/IIa clinical development of UshStat®, a novel gene-based treatment for Usher...

Norgine, a leading European speciality pharmaceutical company and Jubilant Biosys Ltd., Bengaluru based subsidiary of Jubilant Life Sciences Ltd, an integrated pharma & life sciences company of India, announced today, that they have entered into a discovery partnership....

Teva Pharmaceutical Industries Ltd.announced that it has completed its acquisition of Cephalon, Inc. (NASDAQ: CEPH).  The combined company will have a significant presence in over 60 countries and generated approximately $20 billion in revenues on a pro-forma basis for...